Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2− Advanced Breast Cancer
Matthew P. Goetz, Miguel Martin, Eriko Tokunaga, In Hae Park, Jens Huober, Masakazu Toi, Clemens Stoffregen, Sarah Shekarriz, Valerie Andre, M. Corona Gainford, Gregory L. Price, Stephen Johnston
Dive into the research topics of 'Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2− Advanced Breast Cancer'. Together they form a unique fingerprint.